Entekor-0.5 (Entecavir)

Description

Entekor 0.5 mg (Entecavir) belongs to the class of anti-viral drugs indicated against Hepatitis B viral (HBV) infection in adults. Entekor 0.5 (Entecavir) lowers the amount of HBV cells in the body by affecting their ability to multiply (replicate) and infect new liver cells. Additionally, Entekor 0.5 (Entecavir) is also used in HIV patients co-infected with HBV who never had other highly-active anti-retroviral medicines.

Entekor 0.5 mg (Entecavir) improves the worsening condition of the liver by reducing the viral load. However, it is important to inform patients that it is not used to completely cure HBV infection or reduce their chances of procuring liver cancer and scarring of the liver (cirrhosis).

Entecavir is recommended orally once daily in treatment-naïve adult patients with compensated liver disease and over 16 years of age. It is swallowed on an empty stomach at least 2 hours after a meal and 2 hours before the next meal.

Once the Entekor is swallowed, it quickly absorbs in the body in between 30 minutes to 1 hour and 30 minutes. Once absorption is done, the drug binds with HBV cells with 13% affinity. Furthermore, it metabolizes in the liver and gets eliminated (50% of the drug) through urine in roughly 24 hours.